Cost-based COVID-19 vaccination and willingness to pay: A post-pandemic review

Li Ping Wong,Hai Yen Lee,Haridah Alias,Gregory Zimet,Tongyu Liu,Yulan Lin,Zhijian Hu
DOI: https://doi.org/10.1080/21645515.2024.2313860
2024-02-17
Human Vaccines & Immunotherapeutics
Abstract:The primary objective of this paper is to serve as a valuable resource for policymakers who are confronted with the evolving landscape of the coronavirus disease 2019 (COVID-19), considering both free and cost-based vaccination approaches. The potential consequences of shifting from free to cost-based vaccination are explored, encompassing its impact on global vaccine equity and prioritization, economic well-being, healthcare systems and delivery, public health policies, and vaccine distribution strategies. Examining past studies on willingness to pay for the initial COVID-19 vaccine dose and booster shots provides insights into how individuals value COVID-19 vaccinations and underscores the significance of addressing issues related to affordability. If COVID-19 vaccinations incur expenses, using effective communication strategies that emphasize the importance of vaccination and personal health benefits can increase willingness to pay. Making COVID-19 vaccines accessible through public health programs or health insurance can help alleviate financial barriers and increase vaccination rates.
immunology,biotechnology & applied microbiology
What problem does this paper attempt to address?